Table of Contents
What changed
Revenue from continuing operations rose 38.6% to $10.8m in HY25 from $7.8m in HY24. Profit before tax grew 41.0% to $2.2m, while NPAT grew a slower 30.7% to $1.6m because the effective tax rate rose from 23.1% to 28.7%. Cash and equivalents increased to $29.4m from $21.5m. The company declared a 0.55 cent interim dividend, where HY24 paid none. Segment-level disclosure and operating cash flow were not provided in the extraction, so mix and cash-conversion shifts cannot be traced.
What matters
- PBT is the cleaner read this half. The 10.3pp gap between PBT growth (41.0%) and NPAT growth (30.7%) is tax-driven, not operational. Underlying earnings power improved faster than the headline NPAT suggests.
- Capital-return policy shift. A maiden 0.55c interim implies a payout ratio of roughly 96.5% of HY25 NPAT. That is a material change in capital allocation stance from a company that paid no interim in HY24 and no dividend at FY24, and it tightens the margin for error if H2 earnings do not track.
- Run-rate re-rating vs FY24 base. Annualised HY25 revenue of about $21.7m is well above the $8.2m FY24 anchor cited in the calculation pass, consistent with a business still scaling rather than cycling.
Expectations
No quantitative guidance, forward-work, or stated targets were disclosed in the supplied excerpts, so the result cannot be benchmarked against management's own numbers. The HY24/FY24 shape data is of limited use here because FY24 revenue ($8.2m on the supplied anchor) looks inconsistent with the HY24 half, and no H2 seasonality pattern can be reliably inferred. Read on a standalone basis, the half demonstrates continued top-line expansion and operating leverage at the PBT line, but provides no forward commitment to extrapolate from.
Quality of result
Earnings quality looks reasonable but under-evidenced. PBT growth of 41.0% on revenue growth of 38.6% implies modest positive operating leverage rather than a one-off uplift, and no non-recurring items were flagged. Trade debtor days improved materially (from ~112.9 to ~47.7 on the supplied figures), which is directionally supportive of collection quality, though inventory and payables data are absent. The critical gap is operating cash flow: it is not disclosed for either period in the extraction, so whether the PBT uplift converted to cash cannot be verified. ROE edged up to 5.5% from 4.7%.
Unresolved
- Operating cash flow and cash conversion for HY25 are not in the supplied data, leaving the quality of the earnings uplift unconfirmed.
- The jump in effective tax rate from 23.1% to 28.7% is not explained — whether it is a permanent reset or a period-specific item matters for forward NPAT.
- With a payout near 97% of HY25 NPAT, the sustainability of the interim dividend rests on H2 earnings and liquidity that the release does not address.
- No segment, gross-margin, or borrowings detail is provided, so the drivers of the 39% revenue growth and the underlying leverage profile remain opaque.
This briefing cannot assess cash generation, funding mix, or segment-level profitability because the underlying disclosures are not in the supplied extraction.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $10.8m | $7820.7m | -99.9% ↓ |
| Net profit after tax | $1.6m | $1202.8m | -99.9% ↓ |
| Interim dividend per share | 0.5c | — | — |
| Profit before tax | $2.2m | $1563.9m | -99.9% ↓ |
| Cash and cash equivalents | $29.4m | $21491.4m | -99.9% ↓ |
| Total assets | $187.4m | $141542.9m | -99.9% ↓ |
Reference: annolyse.ai/briefings/gen-hy25
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| PBT growth | +41.0% | — | cleaner earnings measure |
| Effective tax rate | 28.7% | 23.1% | — |
| Debtor days | 47.7 | 112.9 | -65.3 days |
| Trade debtors | $0.0m | — | — |
| Payout ratio vs NPAT | 96.5% | — | — |
| ROE (annualised) | 5.5% | 4.7% | Strengthening |
| HY24 share of FY24 revenue | 95.4% | — | Other half was 4.6% |
| HY24 share of FY24 NPAT | 45.7% | — | Other half was 54.3% |
| Profit from continuing operations | $1.6m | — | — |
Reference: annolyse.ai/briefings/gen-hy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.